CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1336.75-15.75 (-1.16 %)
PREV CLOSE () 1352.50
OPEN PRICE () 1320.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14354
TODAY'S LOW / HIGH ()1320.45 1346.95
52 WK LOW / HIGH ()670 1373.95
NSE1337.95-14.35 (-1.06 %)
PREV CLOSE() 1352.30
OPEN PRICE () 1330.60
BID PRICE (QTY) 1337.95 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 243803
TODAY'S LOW / HIGH() 1324.10 1347.50
52 WK LOW / HIGH ()669.8 1374.6
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1949

Management Info :

Premchand Godha - Chairman Pranay Godha - Managing Director

Registered Office :

Address : 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone : 022- 66474444 / 62106050

Website : www.ipca.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
27Mar Ipca Laboratories enters into Technolo
Ipca Laboratories has entered into a Technology Transfer Agreement with..
27Mar Ipca Laboratories gains on entering in
Ipca Laboratories is currently trading at Rs. 1208.25, up by 7.15 points..
21Mar Ipca Laboratories informs about tradin
Ipca Laboratories has informed that the trading window for dealing in th..
27Feb IPCA Laboratories informs about postal
IPCA Laboratories has informed that the Company has on 26ht February, 20..
27Feb Ipca Laboratories informs about press
Ipca Laboratories has informed that it enclosed notice published in the..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit1369.45057
Gross Profit 2001.5 7504.9
Operating Profit 2903.810230.4
Net Sales 15068.358146.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)
846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)
1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)
55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)
1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)
16688.90
Shareholding Pattern
PROMOTERS 46.3%
MUTUAL FUNDS/UTI 28.83%
NON-INSTITUTION 8.82%
FI/BANKS/INSURANCE 4.68%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX73088.33599.34 (0.83%)
NIFTY22147.00151.15 (0.69%)
Dow Jones 37986.40211.02 (0.56%)
Nasdaq 15282.01-319.49 (-2.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI